Coding and non-coding nucleotides': The future of stroke gene therapeutics.
Vishal Chavda1, Kajal Madhwani2
1Department of Pharmacology, Nirma University, Ahmadabad, Gujarat, India.
Genomics
|March 7, 2021
Summary
Recent advancements in stroke therapy focus on RNA modifications and targeted gene therapies. These novel approaches, including noncoding RNAs, show greater potential for neuroprotection and safer treatments than conventional methods.
Area of Science:
- Neurology
- Molecular Biology
- Biotechnology
Background:
- Stroke is a leading cause of death and disability worldwide, necessitating innovative therapeutic strategies.
- Conventional stroke treatments have limitations, driving research into advanced therapeutic modalities.
- Recent years have seen significant exploration of diverse anti-stroke agents.
Purpose of the Study:
- To review recent advancements in stroke therapy, specifically focusing on RNA modifications and targeted gene therapeutics.
- To highlight the potential of genetic therapies, including various noncoding RNAs, as future stroke treatments.
- To compare the efficacy and safety of novel RNA-based therapies against conventional stroke therapeutics.
Main Methods:
- Review of recent scientific literature and clinical trials on stroke therapies.
- Analysis of studies investigating genetic therapies, including noncoding RNAs (ncRNAs), long non-coding RNAs (LncRNAs), small interfering RNAs (siRNAs), microRNAs (miRNAs), and Piwi interacting RNAs (PiWi RNAs).
- Evaluation of the neuroprotective and therapeutic potential of these RNA-based agents.
Main Results:
- Noncoding RNAs (ncRNAs) demonstrate significant potential as targeted therapeutics for stroke.
- RNA-based gene therapies offer improved outcomes and enhanced neuroprotection compared to conventional treatments.
- These advanced genetic therapies present a safer, non-toxic alternative for stroke management.
Conclusions:
- Targeted gene therapy, particularly utilizing RNA modifications, represents a promising frontier in stroke treatment.
- RNA-based therapeutics hold the potential to revolutionize stroke management by offering superior efficacy and safety profiles.
- Further research into ncRNAs and other gene-based strategies is crucial for developing next-generation stroke therapies.
Related Concept Videos
00:59Gene Therapy
26.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.6K
03:06From DNA to Protein
20.9K
The flow of genetic information in cells from DNA to mRNA to protein is described by the central dogma, which states that genes specify the sequence of mRNAs, which in turn specify the sequence of amino acids making up all proteins. The decoding of one molecule to another is performed by specific proteins and RNAs. Because the information stored in DNA is so central to cellular function, it makes intuitive sense that the cell would make mRNA copies of this information for protein synthesis...
20.9K
02:27Nonsense-mediated mRNA Decay
11.2K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.2K
02:30siRNA - Small Interfering RNAs
17.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.6K
01:31Translation
16.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
16.8K